These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23996830)

  • 41. Polymeric nanodroplets: an emerging trend in gaseous delivery system.
    Shende P; Jain S
    J Drug Target; 2019 Dec; 27(10):1035-1045. PubMed ID: 30808239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanocarriers for microRNA delivery in cancer medicine.
    Fernandez-Piñeiro I; Badiola I; Sanchez A
    Biotechnol Adv; 2017; 35(3):350-360. PubMed ID: 28286148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SiRNA delivery: challenges and role of carrier systems.
    Shegokar R; Al Shaal L; Mishra PR
    Pharmazie; 2011 May; 66(5):313-8. PubMed ID: 21699063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review.
    Varshosaz J; Taymouri S
    Curr Pharm Des; 2015; 21(29):4310-28. PubMed ID: 26323421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thiol redox-sensitive cationic polymers for dual delivery of drug and gene.
    Syamala PS; Ramesan RM
    Ther Deliv; 2018 Oct; 9(10):751-773. PubMed ID: 30277132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent advances of using polyhydroxyalkanoate-based nanovehicles as therapeutic delivery carriers.
    Li Z; Loh XJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 27595635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Applications of graphene oxide in case of nanomedicines and nanocarriers for biomolecules: review study.
    Mousavi SM; Hashemi SA; Ghasemi Y; Amani AM; Babapoor A; Arjmand O
    Drug Metab Rev; 2019 Feb; 51(1):12-41. PubMed ID: 30741033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
    Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
    Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Up-to-date Review on Protein-based Nanocarriers in the Management of Cancer.
    Almalki WH
    Curr Drug Deliv; 2024; 21(4):509-524. PubMed ID: 37165498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Budding Alliance of Nanotechnology in RNA Interference Therapeutics.
    Kumawat A; Dapse P; Kumar N; Mishra DK; Maheshwari R; Bhattacharya P; Tekade RK
    Curr Pharm Des; 2018; 24(23):2632-2643. PubMed ID: 30084328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glucose-sensitive polymer nanoparticles for self-regulated drug delivery.
    Zhao L; Xiao C; Wang L; Gai G; Ding J
    Chem Commun (Camb); 2016 Jun; 52(49):7633-52. PubMed ID: 27194104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comprehensive review on immuno-nanomedicine for breast cancer therapy: Technical challenges and troubleshooting measures.
    Saravanakumar K; Anbazhagan S; Pujani Usliyanage J; Vishven Naveen K; Wijesinghe U; Xiaowen H; Vishnu Priya V; Thiripuranathar G; Wang MH
    Int Immunopharmacol; 2022 Feb; 103():108433. PubMed ID: 34922248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
    Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
    Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Strategies To Design and Synthesize Polymer-Based Stimuli-Responsive Drug-Delivery Nanosystems.
    Qin X; Li Y
    Chembiochem; 2020 May; 21(9):1236-1253. PubMed ID: 31889379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RNA cancer nanomedicine: nanotechnology-mediated RNA therapy.
    Ferdows BE; Patel DN; Chen W; Huang X; Kong N; Tao W
    Nanoscale; 2022 Mar; 14(12):4448-4455. PubMed ID: 35080555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advances in structural design of lipid-based nanoparticle carriers for delivery of macromolecular drugs, phytochemicals and anti-tumor agents.
    Angelova A; Garamus VM; Angelov B; Tian Z; Li Y; Zou A
    Adv Colloid Interface Sci; 2017 Nov; 249():331-345. PubMed ID: 28477868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.
    Zhao J; Feng SS
    Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
    Du JZ; Mao CQ; Yuan YY; Yang XZ; Wang J
    Biotechnol Adv; 2014; 32(4):789-803. PubMed ID: 23933109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
    Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
    Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. siRNA applications in nanomedicine.
    Tokatlian T; Segura T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(3):305-15. PubMed ID: 20135697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.